LACTOSE (INDIA)
Back to Balance Sheet
|
LACTOSE (INDIA) Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹45 Cr | ₹25 Cr | ₹26 Cr | ₹15 Cr | ₹12 Cr |
What is the latest Total Current Liabilities ratio of LACTOSE (INDIA) ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹45 Cr |
| Mar2024 | ₹25 Cr |
| Mar2023 | ₹26 Cr |
| Mar2022 | ₹15 Cr |
| Mar2021 | ₹12 Cr |
How is Total Current Liabilities of LACTOSE (INDIA) Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹45 Cr | 76.74 | |
| Mar2024 | ₹25 Cr | -4.04 | |
| Mar2023 | ₹26 Cr | 77.51 | |
| Mar2022 | ₹15 Cr | 28.26 | |
| Mar2021 | ₹12 Cr | - | |
Compare Total Current Liabilities of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹134.1 Cr | -0.2% | 3.5% | -12.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | -0.2% |
3.5% |
-12.4% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses